z-logo
open-access-imgOpen Access
603. Multi-morbidity and Impaired CD4/CD8 Ratios in Older Adults with Well-Controlled HIV
Author(s) -
Oluwatoyin Adeyemi,
Lisa Diep
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy210.610
Subject(s) - medicine , diabetes mellitus , comorbidity , kidney disease , cd4 cd8 ratio , viremia , coronary artery disease , type 2 diabetes , copd , human immunodeficiency virus (hiv) , gastroenterology , cd8 , immunology , endocrinology , lymphocyte subsets , antigen
Background Older age has been associated with impaired CD4 recovery and a low CD4:CD8 ratio is an independent predictor of non-AIDS morbidity/mortality. In this study we describe the overall comorbidity burden and assess factors associated with CD4:CD8 <1 among HIV+ older adults 60 years+ seen at CORE Center, Cook County Health and Hospital System; a safety-net health system. Methods We evaluated demographic, clinical, and lab variables in all HIV+> 60 years who had at least 1 primary care visit from January 1, 2016 to May 31, 2017 at the RMR CORE center. Since HIV viremia is associated with CD4 recovery, analysis on CD4:CD8 ratios was restricted to the patients with viral suppression. Results There were 809 patients with a median age of 63 (range: 60–89) years. Seventy-five percent were male, 74% black, 17% Hispanic and 8% white. Mean CD4 was 538 (+307) cells/mm; 107 (13%) had CD4 < 200 and 675 (84%) had undetectable HIVRNA (<40 copies/mL). 38% were HCV Ab+. Common comorbidities were hypertension 62%, COPD 23%, diabetes 22%, depression 17%, osteoarthritis 15%, neuropathy, chronic kidney disease (CKD) and coronary artery disease (CAD) 13% each. 50% had 1–2 comorbidities and 31% had >3 co-morbidities. Of the 675 patients with suppressed viremia, 470 patient (70%) had CD4:CD8 <1 and 245 (36%) had CD4:CD8 <0.5. Compared with patients with CD4:CD8 >1, patient with CD4:CD8 <1 had lower CD4 counts (451 vs. 739 cells/mm3; P < 0.001), were less likely to have CD4 > 500 (35% vs. 75%; P <0.001), more likely to have CD4 <200 (13% vs. 1%; P <0.001), be male (82% vs. 60%; P < 0.001), HCVab+ (39% vs. 32%; P 0.05). They also trended to have more CAD 7% vs. 4% (P = 0.1) and more CKD 15% vs. 11% (P = 0.2). Conclusion There was a high rate of multi-morbidity among older, predominantly ethnic minorities HIV-infected adults with 56% having >2 comorbidities. In the setting of viral suppression, 70% still had a CD4:CD8 ratio <1 which likely reflects the effects of older age, and lower CD4 nadir. This impaired immune restoration and co-morbidity burden portend a higher risk of non-AIDS morbidity and mortality in these patients and highlights the need for comprehensive care in HIV clinic settings. Disclosures All authors: No reported disclosures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom